Methylene blue and photobiomodulation recover cognitive impairment in hepatic encephalopathy through different effects on cytochrome c-oxidase (2021)

Peer-Reviewed Study · Mendez M; Fidalgo C; Arias JL; Arias N · February 4, 2021

Mendez M et al., 2021-02-04: Rat hepatic-encephalopathy study (5 groups, n=6-7 each, Spain) giving either transcranial 670 nm LED (9 J/cm2 daily x 7 days) or intracranial methylene blue (2.2 ug/0.5 uL into accumbens) – separate arms, not a combination. Both improved the memory deficit but diverged on cytochrome c-oxidase activity.

PBM animals were exposed transcranially to 670 +/- 10 nm LED light at a dose of 9 J/cm2 once a day for 7 days

Mendez M et al., 2021-02-04: Rat hepatic-encephalopathy study (5 groups, n=6-7 each, Spain) giving either transcranial 670 nm LED (9 J/cm2 daily x 7 days) or intracranial methylene blue (2.2 ug/0.5 uL into accumbens) – separate arms, not a combination. Both improved the memory deficit but diverged on cytochrome c-oxidase activity. Animal (rat), N=34 across 5 groups, Spain (Oviedo). MB 2.2 ug/0.5 uL intracranial, single administration; tPBM 670+/-10 nm LED, 9 J/cm2, once daily x 7 days. No combined MB+PBM arm – the paper compares them as parallel interventions on the same target. Funding/COI not in PubMed abstract record. Also filed as MTF-25 (claims C10, C5). Study type: animal.